Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial
- PMID: 18077218
- PMCID: PMC2329576
- DOI: 10.1016/S1474-4422(07)70294-6
Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial
Abstract
Background: The aim of constraint-induced movement therapy (CIMT) is to promote use of a limb that is functionally impaired after a stroke. In one form of CIMT to treat upper limb impairment, use of the less severely affected arm is restricted for many hours each weekday over 2 consecutive weeks. The EXCITE trial has previously shown the efficacy of this intervention for patients 3-9 months poststroke who were followed-up for the next 12 months. We assessed the retention of improvements 24 months after the intervention.
Methods: In the EXCITE trial, 106 of 222 participants who had mild to moderate poststroke impairments were randomly assigned to receive CIMT rather than usual and customary care. We assessed this group of patients every 4 months for the primary outcome measure of impaired upper limb function, as measured with the Wolf motor function test (WMFT) and the motor activity log (MAL). Health-related quality of life, measured with the stroke impact scale (SIS), was a secondary outcome measure. Analysis was per protocol. This trial is registered with ClinicalTrials.gov, number NCT00057018.
Findings: The effects at 24 months after treatment did not decline from those at 12 months for time taken to complete the WMFT (-0.32 s, 95% CI -3.70 to 3.06), for weight lifted in the WMFT (-1.39 kg, -2.74 to -0.04), for WMFT grip strength (-4.39 kg, -6.91 to -1.86), for amount of use in the MAL (-0.17, -0.38 to 0.04), or for how well the limb was used in the MAL (-0.14, -0.34 to 0.06). The additional changes were in the direction of increased therapeutic effect. For the strength components of the WMFT, p<0.0001.
Interpretation: Patients who have mild to moderate impairments 3-9 months poststroke have substantial improvement in functional use of the paretic upper limb and quality of life 2 years after a 2-week CIMT intervention. Thus, this intervention has persistent benefits.
Conflict of interest statement
Figures
Similar articles
-
Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial.JAMA. 2006 Nov 1;296(17):2095-104. doi: 10.1001/jama.296.17.2095. JAMA. 2006. PMID: 17077374 Clinical Trial.
-
Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.Lancet Neurol. 2015 Sep;14(9):893-902. doi: 10.1016/S1474-4422(15)00147-7. Epub 2015 Jul 28. Lancet Neurol. 2015. PMID: 26231624 Clinical Trial.
-
Modified Constraint-Induced Movement Therapy is a feasible and potentially useful addition to the Community Rehabilitation tool kit after stroke: A pilot randomised control trial.Aust Occup Ther J. 2018 Dec;65(6):503-511. doi: 10.1111/1440-1630.12488. Epub 2018 Jun 19. Aust Occup Ther J. 2018. PMID: 29920688 Clinical Trial.
-
Comparing Ways to Treat Arm Weakness Due to Stroke [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 May. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 May. PMID: 38556969 Free Books & Documents. Review.
-
Therapeutic effect of adjuvant therapy added to constraint-induced movement therapy in patients with subacute to chronic stroke: a systematic review and meta-analysis.Disabil Rehabil. 2024 Sep;46(18):4098-4112. doi: 10.1080/09638288.2023.2269843. Epub 2023 Oct 19. Disabil Rehabil. 2024. PMID: 37855247 Review.
Cited by
-
Repetitive Peripheral Sensory Stimulation and Upper Limb Performance in Stroke: A Systematic Review and Meta-analysis.Neurorehabil Neural Repair. 2018 Oct;32(10):863-871. doi: 10.1177/1545968318798943. Epub 2018 Sep 10. Neurorehabil Neural Repair. 2018. PMID: 30198383 Free PMC article.
-
A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation.Iran J Child Neurol. 2019 Spring;13(2):17-28. Iran J Child Neurol. 2019. PMID: 31037074 Free PMC article. Review.
-
Use it and improve it or lose it: interactions between arm function and use in humans post-stroke.PLoS Comput Biol. 2012 Feb;8(2):e1002343. doi: 10.1371/journal.pcbi.1002343. Epub 2012 Feb 16. PLoS Comput Biol. 2012. PMID: 22761551 Free PMC article. Clinical Trial.
-
Effectiveness of finger-equipped electrode (FEE)-triggered electrical stimulation improving chronic stroke patients with severe hemiplegia.Brain Inj. 2013;27(1):114-9. doi: 10.3109/02699052.2012.729283. Brain Inj. 2013. PMID: 23252442 Free PMC article.
-
Error-augmented bimanual therapy for stroke survivors.NeuroRehabilitation. 2018;43(1):51-61. doi: 10.3233/NRE-182413. NeuroRehabilitation. 2018. PMID: 30040762 Free PMC article. Clinical Trial.
References
-
- Taub E, Miller NE, Novack TA, et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil. 1993 Apr;74(4):347–354. - PubMed
-
- Taub E, Uswatte G, Elbert T. New treatments in neurorehabilitation founded on basic research. Nat Rev Neurosci. 2002 Mar;3(3):228–236. - PubMed
-
- Ostendorf CG, Wolf SL. Effect of forced use of the upper extremity of a hemiplegic patient on changes in function. A single-case design. Phys Ther. 1981 Jul;61(7):1022–1028. - PubMed
-
- Wolf SL, Lecraw DE, Barton LA, Jann BB. Forced use of hemiplegic upper extremities to reverse the effect of learned nonuse among chronic stroke and head-injured patients. Exp Neurol. 1989 May;104(2):125–132. - PubMed
-
- Page SJ, Sisto S, Johnston MV, Levine P. Modified constraint-induced therapy after subacute stroke: a preliminary study. Neurorehabil Neural Repair. 2002 Sep;16(3):290–295. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials